These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10520793)

  • 1. Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure: evidence of impaired reactivity to nitroglycerin.
    Vavuranakis M; Stefanadis C; Triandaphyllidi E; Toutouzas K; Toutouzas P
    J Am Coll Cardiol; 1999 Oct; 34(4):1075-81. PubMed ID: 10520793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of coronary artery distensibility by intravascular ultrasound. Application of simultaneous measurements of luminal area and pressure.
    Nakatani S; Yamagishi M; Tamai J; Goto Y; Umeno T; Kawaguchi A; Yutani C; Miyatake K
    Circulation; 1995 Jun; 91(12):2904-10. PubMed ID: 7796499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilation in patients with coronary artery disease.
    Kal JE; Vergroesen I; van Wezel HB
    Anesth Analg; 1999 Feb; 88(2):271-8. PubMed ID: 9972740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate timing of nitroglycerin prior to intravascular ultrasound.
    Ahmed B; Martinez JD; Schevchuck A; Ahmed S; Schrader R; Peralta MA; Sheldon MW; Ricciardi MJ
    J Invasive Cardiol; 2012 Sep; 24(9):422-6. PubMed ID: 22954560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilator responses of coronary conduit and resistance arteries to continuous nitroglycerin infusion in humans: a Doppler guide wire study.
    Kawabata T; Fujii T; Hiro T; Yasumoto K; Yamada J; Yano M; Miura T; Matsuzaki M
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):764-9. PubMed ID: 11117377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis.
    Adams MR; Robinson J; McCredie R; Seale JP; Sorensen KE; Deanfield JE; Celermajer DS
    J Am Coll Cardiol; 1998 Jul; 32(1):123-7. PubMed ID: 9669259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery.
    Waxman S; Moreno R; Rowe KA; Verrier RL
    J Am Coll Cardiol; 1999 Jun; 33(7):2073-7. PubMed ID: 10362216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound.
    Sudhir K; MacGregor JS; Barbant SD; Foster E; Fitzgerald PJ; Chatterjee K; Yock PG
    J Am Coll Cardiol; 1993 Apr; 21(5):1261-8. PubMed ID: 8459086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease.
    Jeremias A; Spies C; Herity NA; Pomerantsev E; Yock PG; Fitzgerald PJ; Yeung AC
    Heart; 2000 Sep; 84(3):314-9. PubMed ID: 10956298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.
    Gage JE; Hess OM; Murakami T; Ritter M; Grimm J; Krayenbuehl HP
    Circulation; 1986 May; 73(5):865-76. PubMed ID: 3084124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.
    Nitenberg A; Valensi P; Sachs R; Dali M; Aptecar E; Attali JR
    Diabetes; 1993 Jul; 42(7):1017-25. PubMed ID: 8513969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired arterial but not venous responsiveness to nitroglycerin in non-insulin-dependent diabetes mellitus.
    Huvers FC; Schaper NC; Houben AJ; Hofstra L; Kitslaar PJ; De Leeuw PW; Nieuwenhuijzen Kruseman AC
    Eur J Clin Invest; 1997 May; 27(5):360-5. PubMed ID: 9179541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease--evaluation by contrast echocardiography and pulsed tissue Doppler.
    Dounis V; Siegmund T; Hansen A; Jensen J; Schumm-Draeger PM; von Bibra H
    Diabetologia; 2006 Nov; 49(11):2729-40. PubMed ID: 17016696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of endothelium-derived nitric oxide to coronary arterial distensibility: an in vivo two-dimensional intravascular ultrasound study.
    Sudhir K; Mullen WL; Hausmann D; Fitzgerald PJ; Chou TM; Yock PG; Chatterjee K
    Am Heart J; 1995 Apr; 129(4):726-32. PubMed ID: 7900624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study.
    Martin-Reyes R; de la Torre Hernandez JM; Franco-Pelaez J; Lopez-Palop R; Telleria Arrieta M; Amat Santos IJ; Carrillo Saez P; Sanchez-Recalde A; Sanmartin Pena JC; Garcia Camarero T; Brugaletta S; Gimeno de Carlos F; Pinero A; Sorto Sanchez DC; Frutos A; Lasa Larraya G; Navarro F; Farre J
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):262-9. PubMed ID: 26213338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic coronary-flow regulation and exogenous nitric oxide in human coronary artery disease: assessment by intravenous administration of nitroglycerin.
    Kal JE; Van Wezel HB; Porsius M; Vergroesen I; Spaan JA
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):7-15. PubMed ID: 10630728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. An in vivo intravascular ultrasound study.
    Vavuranakis M; Stefanadis C; Toutouzas K; Pitsavos C; Spanos V; Toutouzas P
    Eur Heart J; 1997 Jul; 18(7):1090-4. PubMed ID: 9243141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of coronary responses to various doses of intracoronary nitroglycerin.
    Feldman RL; Marx JD; Pepine CJ; Conti CR
    Circulation; 1982 Aug; 66(2):321-7. PubMed ID: 6807566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.
    Shen Y; Yang ZK; Hu J; Wang XQ; Dai Y; Zhang S; Zhang RY; Lu L; Ding FH; Shen WF
    Cardiovasc Diabetol; 2018 Jun; 17(1):76. PubMed ID: 29859086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nitroglycerin and verapamil on coronary arterial distensibility as assessed by intravascular ultrasound.
    Akima T; Makkar R; Nishioka T; Dohad S; Iida K; Goland S; Kar S; Luo H; Siegel RJ
    J Invasive Cardiol; 2009 Apr; 21(4):162-7. PubMed ID: 19342754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.